Transactions

Novo Nordisk A/S’s acquisition of Forma Therapeutics Holdings, Inc.

Date Announced:
09/01/2022

client:
Novo Nordisk A/S

Status:
Pending

Value:
$1.1 billion

Clear all

Download CSV